269 related articles for article (PubMed ID: 25929897)
1. Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial.
Hauser G; Salkic N; Vukelic K; JajacKnez A; Stimac D
Medicine (Baltimore); 2015 May; 94(17):e685. PubMed ID: 25929897
[TBL] [Abstract][Full Text] [Related]
2. Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study.
Navarro-Rodriguez T; Silva FM; Barbuti RC; Mattar R; Moraes-Filho JP; de Oliveira MN; Bogsan CS; Chinzon D; Eisig JN
BMC Gastroenterol; 2013 Mar; 13():56. PubMed ID: 23530767
[TBL] [Abstract][Full Text] [Related]
3. Can probiotics improve efficiency and safety profile of triple Helicobacter pylori eradication therapy? A prospective randomized study.
Grgov S; Tasić T; Radovanović-Dinić B; Benedeto-Stojanov D
Vojnosanit Pregl; 2016 Nov; 73(11):1044-9. PubMed ID: 29328644
[TBL] [Abstract][Full Text] [Related]
4. Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance.
Çekin AH; Şahintürk Y; Akbay Harmandar F; Uyar S; Yolcular BO; Çekin Y
Turk J Gastroenterol; 2017 Jan; 28(1):3-11. PubMed ID: 28007678
[TBL] [Abstract][Full Text] [Related]
5. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
6. Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand.
Srinarong C; Siramolpiwat S; Wongcha-um A; Mahachai V; Vilaichone RK
Asian Pac J Cancer Prev; 2014; 15(22):9909-13. PubMed ID: 25520127
[TBL] [Abstract][Full Text] [Related]
7. A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection.
Hsu PI; Kao SS; Wu DC; Chen WC; Peng NJ; Yu HC; Wang HM; Lai KH; Cheng JS; Chen A; Chuah SK; Tsay FW;
Medicine (Baltimore); 2015 Dec; 94(48):e2104. PubMed ID: 26632893
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
Cindoruk M; Erkan G; Karakan T; Dursun A; Unal S
Helicobacter; 2007 Aug; 12(4):309-16. PubMed ID: 17669103
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children.
Szajewska H; Albrecht P; Topczewska-Cabanek A
J Pediatr Gastroenterol Nutr; 2009 Apr; 48(4):431-6. PubMed ID: 19330931
[TBL] [Abstract][Full Text] [Related]
10. Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.
Bochenek WJ; Peters S; Fraga PD; Wang W; Mack ME; Osato MS; El-Zimaity HM; Davis KD; Graham DY;
Helicobacter; 2003 Dec; 8(6):626-42. PubMed ID: 14632678
[TBL] [Abstract][Full Text] [Related]
11. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
Wong BC; Xiao SD; Hu FL; Qian SC; Huang NX; Li YY; Hu PJ; Daldiyono ; Manan C; Lesmana L; Carpio RE; Perez JY; Fock KM; Kachintorn U; Phornphutkul K; Kullavanijaya P; Ho J; Lam SK
Aliment Pharmacol Ther; 2000 Feb; 14(2):217-24. PubMed ID: 10651663
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
Ellenrieder V; Boeck W; Richter C; Marre R; Adler G; Glasbrenner B
Scand J Gastroenterol; 1999 Aug; 34(8):750-6. PubMed ID: 10499474
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics.
Ziemniak W
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():123-41. PubMed ID: 17033111
[TBL] [Abstract][Full Text] [Related]
14. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H
World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544
[TBL] [Abstract][Full Text] [Related]
15. High Effective of 14-Day High-Dose PPI- Bismuth-Containing Quadruple Therapy with Probiotics Supplement for Helicobacter Pylori Eradication: A Double Blinded-Randomized Placebo-Controlled Study.
Poonyam P; Chotivitayatarakorn P; Vilaichone RK
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2859-2864. PubMed ID: 31554388
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children.
Dehghani SM; Erjaee A; Imanieh MH; Haghighat M
Dig Dis Sci; 2009 Aug; 54(8):1720-4. PubMed ID: 19005755
[TBL] [Abstract][Full Text] [Related]
17. Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial.
McNicholl AG; Molina-Infante J; Lucendo AJ; Calleja JL; Pérez-Aisa Á; Modolell I; Aldeguer X; Calafat M; Comino L; Ramas M; Callejo Á; Badiola C; Serra J; Gisbert JP
Helicobacter; 2018 Oct; 23(5):e12529. PubMed ID: 30141228
[TBL] [Abstract][Full Text] [Related]
18. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.
Nista EC; Candelli M; Cremonini F; Cazzato IA; Zocco MA; Franceschi F; Cammarota G; Gasbarrini G; Gasbarrini A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1181-8. PubMed ID: 15569121
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
Treiber G; Wittig J; Ammon S; Walker S; van Doorn LJ; Klotz U
Arch Intern Med; 2002 Jan; 162(2):153-60. PubMed ID: 11802748
[TBL] [Abstract][Full Text] [Related]
20. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.
Cremonini F; Di Caro S; Covino M; Armuzzi A; Gabrielli M; Santarelli L; Nista EC; Cammarota G; Gasbarrini G; Gasbarrini A
Am J Gastroenterol; 2002 Nov; 97(11):2744-9. PubMed ID: 12425542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
